When she first stepped into urgent care in early December, Maggie O'Neil wondered whether her unaccounted-for bruises and fatigue were worth the wait for a clinician. "I thought I had low iron or ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to ...

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML) who have ...

The immune system serves as the body’s primary defense against illness, making its maintenance crucial for overall health. While basic practices like hand washing and balanced nutrition form the ...

PROOF-OF-CONCEPT: ANT308 has shown strong single-agent anti-leukemia activity in two AML mouse models and synergistic ... on human T cells, overcoming immune suppression in the tumor microenvironment.

The results were detected by a chemiluminescent imaging system (Champchemi). Primary antibodies targeting BATF were ... analyses systematically revealed relationships between BATF expression and the ...

Moreover, a part of AML-DC might exert tolerogenic effects on the immune system. Further investigation on this immunotherapeutical approach is necessary to define the best antigen format for this ...

CloseCurlyDoubleQuote; LYT-200 exerts its therapeutic effects in AML by killing cancer cells directly via apoptosis and DNA damage as well as reactivating central anti-cancer effectors of the immune ...